Study of Bavituximab in Patients With Chronic Hepatitis C Virus Infection
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and tolerability of bavituximab when
administered via a vein as a single infusion and to examine how bavituximab behaves in the
body and how it affects the amount of hepatitis C virus in individuals with chronic
infection.